142 related articles for article (PubMed ID: 25483061)
1. The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation.
Lu H; Liu B; Zhang FJ; Zhang J; Dong R; Chen L; Qu DM; Lu Y; Yu BW
Cell Cycle; 2014; 13(24):3892-902. PubMed ID: 25483061
[TBL] [Abstract][Full Text] [Related]
2. SENP2 regulates MEF2A de-SUMOylation in an activity dependent manner.
Lu H; Liu B; You S; Chen L; Dongmei Q; Gu M; Lu Y; Chen Y; Zhang F; Yu B
Mol Biol Rep; 2013 Mar; 40(3):2485-90. PubMed ID: 23224591
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.
Selby TL; Biel N; Varn M; Patel S; Patel A; Hilding L; Ray A; Ross T; Cramblet WT; Moss CR; Lowrey AJ; Bentz GL
Sci Rep; 2019 Jul; 9(1):9523. PubMed ID: 31266997
[TBL] [Abstract][Full Text] [Related]
4. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
[TBL] [Abstract][Full Text] [Related]
5. An essential role of small ubiquitin-like modifier (SUMO)-specific Protease 2 in myostatin expression and myogenesis.
Qi Y; Zuo Y; Yeh ET; Cheng J
J Biol Chem; 2014 Feb; 289(6):3288-93. PubMed ID: 24344126
[TBL] [Abstract][Full Text] [Related]
6. Regulation of E2F1 by APC/C Cdh1 via K11 linkage-specific ubiquitin chain formation.
Budhavarapu VN; White ED; Mahanic CS; Chen L; Lin FT; Lin WC
Cell Cycle; 2012 May; 11(10):2030-8. PubMed ID: 22580462
[TBL] [Abstract][Full Text] [Related]
7. APC/C (Cdh1) controls the proteasome-mediated degradation of E2F3 during cell cycle exit.
Ping Z; Lim R; Bashir T; Pagano M; Guardavaccaro D
Cell Cycle; 2012 May; 11(10):1999-2005. PubMed ID: 22580460
[TBL] [Abstract][Full Text] [Related]
8. Cdh1, a substrate-recruiting component of anaphase-promoting complex/cyclosome (APC/C) ubiquitin E3 ligase, specifically interacts with phosphatase and tensin homolog (PTEN) and promotes its removal from chromatin.
Choi BH; Pagano M; Huang C; Dai W
J Biol Chem; 2014 Jun; 289(25):17951-9. PubMed ID: 24811168
[TBL] [Abstract][Full Text] [Related]
9. Cdh1 is an antagonist of the spindle assembly checkpoint.
Nagai M; Ushimaru T
Cell Signal; 2014 Oct; 26(10):2217-22. PubMed ID: 25025567
[TBL] [Abstract][Full Text] [Related]
10. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.
Ran Y; Liu TT; Zhou Q; Li S; Mao AP; Li Y; Liu LJ; Cheng JK; Shu HB
J Mol Cell Biol; 2011 Oct; 3(5):283-92. PubMed ID: 22028379
[TBL] [Abstract][Full Text] [Related]
11. SUMO-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cells.
Tan MY; Mu XY; Liu B; Wang Y; Bao ED; Qiu JX; Fan Y
Cell Physiol Biochem; 2013; 32(3):542-8. PubMed ID: 24008762
[TBL] [Abstract][Full Text] [Related]
12. Cdh1 regulates craniofacial development via APC-dependent ubiquitination and activation of Goosecoid.
Shao R; Liu J; Yan G; Zhang J; Han Y; Guo J; Xu Z; Yuan Z; Liu J; Malumbres M; Wan L; Wei W; Zou W
Cell Res; 2016 Jun; 26(6):699-712. PubMed ID: 27126000
[TBL] [Abstract][Full Text] [Related]
13. Hippo signaling is intrinsically regulated during cell cycle progression by APC/C
Kim W; Cho YS; Wang X; Park O; Ma X; Kim H; Gan W; Jho EH; Cha B; Jeung YJ; Zhang L; Gao B; Wei W; Jiang J; Chung KS; Yang Y
Proc Natl Acad Sci U S A; 2019 May; 116(19):9423-9432. PubMed ID: 31000600
[TBL] [Abstract][Full Text] [Related]
14. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
[TBL] [Abstract][Full Text] [Related]
15. The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels.
Chen X; Zhang Y; Ren X; Su Q; Liu Y; Dang X; Qin Y; Yang X; Xing Z; Shen Y; Wang Y; Bai Z; Yeh ETH; Wu H; Qi Y
J Biol Chem; 2021 Oct; 297(4):101183. PubMed ID: 34509475
[TBL] [Abstract][Full Text] [Related]
16. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.
Xiao N; Li H; Yu W; Gu C; Fang H; Peng Y; Mao H; Fang Y; Ni W; Yao M
FASEB J; 2019 Jan; 33(1):163-174. PubMed ID: 29969578
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition.
Badodi S; Baruffaldi F; Ganassi M; Battini R; Molinari S
Cell Cycle; 2015; 14(10):1517-28. PubMed ID: 25789873
[TBL] [Abstract][Full Text] [Related]
18. Degradation of FBXO31 by APC/C is regulated by AKT- and ATM-mediated phosphorylation.
Choppara S; Malonia SK; Sankaran G; Green MR; Santra MK
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):998-1003. PubMed ID: 29343641
[TBL] [Abstract][Full Text] [Related]
19. The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3.
Wang H; You G
Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1293-1301. PubMed ID: 31054272
[TBL] [Abstract][Full Text] [Related]
20. Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2.
Itahana Y; Yeh ET; Zhang Y
Mol Cell Biol; 2006 Jun; 26(12):4675-89. PubMed ID: 16738331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
